Tarsus Pharmaceuticals Intangible Assets

Tarsus Pharmaceuticals (TARS) currently reports a intangible assets of $6.9M as of June 2026. That compares with $7.8M in the prior-year period — down 12.2% year over year. Use the charts on this page to explore Tarsus Pharmaceuticals's intangible assets history and peer comparisons.

Tarsus Pharmaceuticals's intangible assets decreased from $7.8M to $6.9M — a 12.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Tarsus Pharmaceuticals reported $6.9M in intangible assets as of June 2026. That compares with $7.8M in the prior-year period — down 12.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $6.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Tarsus Pharmaceuticals, and consider following TARS for alerts when major investors trade the stock.

Tarsus Pharmaceuticals is classified in the Healthcare sector. On intangible assets, it currently shows $6.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TARS with unrelated industries.